Private Equity
GHO wins another pharma services auction while KKR and GIP buy CyrusOne.
2 min read · 15 November 2021
The health outcomes research (HEOR) and Real-World Evidence research organization joins GHO's growing umbrella of pharma services companies taking a transatlantic strategy.
3 min read · 15 November 2021
The $90.50 per share purchase price reflects a premium of approximately 25% to CyrusOne’s closing stock price on September 27, 2021, the last full trading day prior to market speculation regarding a potential sale.
10 min read · 15 November 2021
Prodege provides its partners with marketing, data, and analytics solutions that enable leading brands and agencies to gather insights, target their core audiences, acquire new customers, boost engagement, increase revenue, and drive brand loyalty and product adoption.
3 min read · 15 November 2021
This marks the second investment for PestCo, a platform formed to consolidate the highly fragmented pest control industry.
2 min read · 15 November 2021
SEC's Gensler talks PE transparency and Five Arrow's Stepping Stones hits the market.
2 min read · 12 November 2021
The firm invests behind two longtime executives with prior leadership experience at companies including Multi Packaging Solutions and Westrock.
2 min read · 11 November 2021
SEC's Gensler talks PE transparency while Five Arrow's Stepping Stones hits the market.
4 min read · 11 November 2021
A logical buyer of USOSM, one Oak Hill partner previously led InTandem Capital's investment in Paradigm Oral Surgery, one of few other practice management platforms focused on oral surgeons.
3 min read · 11 November 2021
The provider of behavioral health services to school-age children fielded first-round bids last week, sources said.
2 min read · 10 November 2021
